Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II

British Journal of Haematology

Volumn 106, Issue 4, 1999, Pages 1045-1048

  Van der Werff ten Bosch, Jutte ^a   Delabie, Jan ^a   Böhler, Thomas ^b   Verschuere, Johan ^c   Thielemans, Kris ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

Adult; ALPS; Fas; Lymphadenopathy; T zone lymphoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHILD; CLINICAL EXAMINATION; FATHER CHILD RELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; SCHOOL CHILD; T CELL LYMPHOMA;

ADULT; AUTOIMMUNE DISEASES; CHILD; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA, T-CELL, PERIPHERAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; SPLENOMEGALY; SYNDROME;

EID: 0032845597     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01643.x     Document Type: Article

References (11)

1. Beltinger, C., Böhler, T., Karajew, L., Ludwig, W.D., Schrappe, M. & Debatin, K.M. (1998) Mutation analysis of CD95 (APO-1/Pas) in childhood B-lineage acute lymphoblastic leukaemia. British Journal of Haematology, 102, 722-728.
2. Canale, V.C. & Smith, C.H. (1967) Chronic lymphadenopathy simulating malignant lymphoma. Journal of Pediatrics, 70, 891-899.
3. Dianzani, U., Bragarde, M., DiFranco, D., Alliaudi, C., Scagni, P., Buonfiglio, D., Redoglia, V., Bonisonni, S., Correra, A., Dianzani, I. & Ramenghi, U. (1997) Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood, 89, 2871-2879.
4. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, LA., Lin, A.Y., Strober, W., Lenardo, M.J. & Puck, J.M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human lymphoproliferative syndrome. Cell, 81, 935-946.
5. Infante, A.J., Britton, H.A., DeNapoli, T., Middleton, L.A., Lenardo, M.J., Jackson, C.E., Wang. J., Fleisher, T., Straus, S.E. & Puck, J.M. (1998) The clinical spectrum In a large kindred with autoimmune lymphoproliferative syndrome caused by a Pas mutation that impairs lymphocyte apoptosis. Journal of Pediatrics, 133, 629-633.
6. Jackson, C.E., Fischer, R.E., Hsu, A.P., Anderson. S.M., Choi, Y, Wang, J.K., Fleisher, T.A., Middelton, L.A., Sneller, M.C., Lenardo, M.J., Straus, S.E. & Puck, J.M. (1999) Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. American Journal of Human Genetics, 64, 1002-1014.
7. Lim, M.S., Straus, S.E., Dale, J.K., Fleisher, T., Stetler-Stevenson, M., Strober, W., Sneller, M., Puck, J., Lenardo, M.J., Elinotoba-Johnson, K.S.J., Lin, A.Y, Raffels, M. & Jaffe, E.S. (1998) Pathological findings in human autoimmune lymphoproliferative syndrome. American Journal of Pathology, 153, 1541-1550.
8. Siegert, W., Nerl, C., Engelhard, M., Brittinger, G., Tiemann, M., Parwaresk, R., Heinz, R. & Huhn, D. (1994) Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepithelioid cell (Lennert's) lymphoma und T-zone lymphoma. British Journal of Haematology, 87, 529-534.
9. Sneller, M.C., Wang J., Dale, J.K., Strober, W., Middelton, L.A., Youngnim, C., Fleisher, T.A., Lim, M.S., Jaffe, E.S., Puck, J.M., Lenardo, M.J. & Straus, S.E. (1997) Clinical, immunologic, and genetic factors of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood, 89, 1341-1348.
10. Takagi, N., Nakamura, S., Ueda, R., Osada, H., Obata, Y, Kitoh, K., Suchi, T. & Takahashi, T. (1992) A phenotypic and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: angioimmunoblastic lymphoma. T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer, 69, 2571-2582.
11. Vaishnaw, A.K., Orlinick, J.R., Chu, J.L., Krammer, P.H., Chao, M.V. & Elkon, K.B. (1999) The molecular basis for apoptotic defects in patients with CD95 (Fas/APO-1) mutations, Journal of Clinical investigation, 103, 355-363.